From: Assessment of Survivor Concerns (ASC): A newly proposed brief questionnaire
 | Responders | Non-responders | Total | |||
---|---|---|---|---|---|---|
 | n | % | n | % | n | % |
Age | Â | Â | Â | Â | Â | Â |
Under 50 | 117 | 15.5 | 116 | 20.4 | 233 | 17.6 |
50–65 | 293 | 38.9 | 200 | 35.1 | 493 | 37.3 |
Over 65 | 343 | 45.6 | 254 | 44.6 | 597 | 45.1 |
Sex | Â | Â | Â | Â | Â | Â |
Female | 494 | 65.6 | 360 | 63.2 | 854 | 64.6 |
Male | 259 | 34.4 | 210 | 36.8 | 469 | 35.4 |
Marital Status* | Â | Â | Â | Â | Â | Â |
With Partner | 524 | 69.6 | 346 | 60.7 | 870 | 65.8 |
No Partner | 221 | 29.3 | 219 | 38.4 | 440 | 33.3 |
Ethnicity* | Â | Â | Â | Â | Â | Â |
Japanese | 321 | 42.6 | 213 | 37.4 | 534 | 40.4 |
Caucasian | 248 | 32.9 | 153 | 26.8 | 401 | 30.3 |
Hawaiian | 100 | 13.3 | 112 | 19.6 | 212 | 16.0 |
Filipino | 79 | 10.5 | 84 | 14.7 | 163 | 12.3 |
Other | 5 | 0.7 | 9 | 1.6 | 14 | 1.1 |
Treatment | Â | Â | Â | Â | Â | Â |
Surgery | 688 | 91.4 | 522 | 91.6 | 1210 | 91.5 |
Chemotherapy | 92 | 12.2 | 60 | 10.5 | 152 | 11.5 |
Radiation | 300 | 39.8 | 192 | 33.7 | 492 | 37.2 |
Hormone | 160 | 21.2 | 95 | 16.7 | 255 | 19.3 |
Site* | Â | Â | Â | Â | Â | Â |
Breast | 296 | 39.3 | 173 | 30.4 | 469 | 35.4 |
Digestive | 108 | 14.3 | 83 | 14.6 | 191 | 14.4 |
Prostate | 101 | 13.4 | 69 | 12.1 | 170 | 12.8 |
Other | 248 | 32.9 | 245 | 43.0 | 493 | 37.3 |
Total | 753 | 100.0 | 570 | 100.0 | 1323 | 100.0 |